4-phenylsulfanyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzamide | 1377996-98-9

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 4-phenylsulfanyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzamide
• CAS: 1377996-98-9
• 化学式: C₂₂H₂₈N₂OS
• 分子量: 368.543
• InChiKey: VOXMADQJUSGJMQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  26
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2,2,6,6-四甲基哌啶胺 、 4-苯基硫烷基苯甲酸 在 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 12.5h， 生成 4-phenylsulfanyl-N-(2,2,6,6-tetramethylpiperidin-4-yl)benzamide
  参考文献：
  名称：

  Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2

  摘要：

  The identification and development of a novel series of small molecule Enhancer of Zeste Homologue 2 (EZH2) inhibitors is described. A concise and modular synthesis enabled the rapid development of structure activity relationships, which led to the identification of 44 as a potent, SAM-competitive inhibitor of EZH2 that dose-dependently decreased global H3K27me3 in KARPAS-422 lymphoma cells.

  DOI：

  10.1021/ml400494b

文献信息

• [EN] MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF<br/>[FR] MODULATEURS D'ENZYMES DE MODIFICATION PAR MÉTHYLATION, COMPOSITIONS ET UTILISATIONS ASSOCIÉES
  申请人：CONSTELLATION PHARMACEUTICALS

  公开号：WO2012068589A2

  公开（公告）日：2012-05-24

  Agents for modulating methyl modifying enzymes, compositions and uses thereof are provided herein.
• Discovery and Optimization of Tetramethylpiperidinyl Benzamides as Inhibitors of EZH2
  作者：Christopher G. Nasveschuk、Alexandre Gagnon、Shivani Garapaty-Rao、Srividya Balasubramanian、Robert Campbell、Christina Lee、Feng Zhao、Louise Bergeron、Richard Cummings、Patrick Trojer、James E. Audia、Brian K. Albrecht、Jean-Christophe P. Harmange

  DOI：10.1021/ml400494b

  日期：2014.4.10

  The identification and development of a novel series of small molecule Enhancer of Zeste Homologue 2 (EZH2) inhibitors is described. A concise and modular synthesis enabled the rapid development of structure activity relationships, which led to the identification of 44 as a potent, SAM-competitive inhibitor of EZH2 that dose-dependently decreased global H3K27me3 in KARPAS-422 lymphoma cells.